Platelet-Vessel Wall Interaction

Baumgartner HR Haudenschild C. Adhesion of blood platelets to subendothelium. Ann NY Acad Sci 1972; 201: 22–36.

Sakariassen KS Aarts PAMM de Groot PhG Houdijk WPM Sixma JJ . A perfusion chamber to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med 1983; 102: 522–35.

Muggli R Baumgartner HR Tschopp Tb Keller H. Automated microdensitometry protein assay as a measure for platelet adhesion and aggregation on collagen coated slides under controlled and flow conditions. J Lab Clin Med 1980; 95: 195–207.

Turitto VT Weiss HJ . Platelet interaction with subendothelium in flowing rabbit blood: Effect of blood shear rate. Microvasc Res 1979; 17: 38–54.

Weiss HJ Turitto VT Baumgartner HR . The effect of shear rate on platelet interaction with subendothelium in titrated and native blood. Shear rate dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978; 92: 750–64.

Wang NH Keller KH . Solute transport induced by erythrocyte motion in shear flow. Trans Am Soc Artific Org 1979; 25: 14–18.

Goldsmith HL Turitto VT . Rheological aspects of thrombosis and haemostasis: Basic principles and application. Thromb Haemost 1986; 55: 415–35.

Tschopp TB Weiss HJ Baumgartner HR . Interaction of thrombasthenic platelets with subendothelium: Normal adhesion and absent aggregation. Experientia 1975; 31: 113–15.

Karino T Goldsmith HL . Rheological factors in thrombosis and haemostasis. In: Bloom AL Thomas DP eds. Haemostasis and thrombosis, 2nd edition. Edinburgh: Churchill Livingstone 1987: 739–55.

Aarts PAMM Banga JD van Houwelingen HC Heethaar RM Sixma JJ . Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: A double-blind cross-over study in patients with intermittent claudication. Blood 1986; 67: 1474–81.

Aarts PAMM Bolhuis PA Sakariassen KS Heethaar RM Sixma JJ . Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood 1984; 62: 214–17.

Aarts PAMM Heethaar RM Sixma JJ . Red blood cell deformability influences platelet vessel wall interaction in flowing blood. Blood 1984; 62: 1228–33.

Zwaginga JJ Ijsseldijk MJW de Groot PhG Kooistra M Vos J van Es A Dorhout-Mees EJ Stuyvenberg A Sixma JJ . Treatment of uremic anemia with recombinant erythropoietin reduces the defects in platelet adhesion and aggregation caused by uremic plasma. Thromb Haemost 1991; 66: 638–47.

van Breugel HHFI de Groot PhG Sixma JJ . The role of plasma viscosity in platelet adhesion. Blood 1992; 80: 953–59.

Ginsberg MH Loftus JG Plow EF . Cytoadhesins, integrins and platelets. Thromb Haemost 1988; 59: 1–6.

Sixma JJ Nievelstein PFEM Houdijk WPM van Breugel H Hindriks G de Groot PhG. Adhesion of blood platelets to isolated components of the vessel wall. Ann N Y Acad Sci 1987; 509: 103–117.

Houdijk WPM Sakariassen KS Nievelstein PFEM Sixma JJ . Role of factor VII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomelic and fibrillar collagen types I and III. J Clin Invest 1985; 75: 531–40.

Hantgan RR Hindriks G Taylor RG Sixma JJ de Groot PhG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb-IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345–53.

Beumer S Orlando E de Groot PhG Sixma JJ . Platelet adhesion to isolated fibronectin under flow and static conditions: The contribution of GPIIb-IIIa, VLA-5 and GPIb. Thromb Haemost 1991; 65: 811 (abstract).

van Mourik JA Bouma BN Labruyere WT de Graaf S Mochtar IA . Factor VIII, a series of homologous oligomers and a complex of two proteins. Thromb Res 1974; vmr-4: 155–64.

Houdijk WPM de Groot PhG Nievelstein PFEM Sakariassen KS Sixma JJ . Von Willebrand factor and fibronectin but not thrombospondin are involved in platelet adhesion to the extracellular matrix of human vascular endothelial cells. Arteriosclerosis 1986; 6: 24–33.

Zimmerman TS Meyer D. Structure and function of factor VIII and von Willebrand factor. In: Bloom AL Thomas DP eds. Haemostasis and thrombosis, 2nd edition. Edinburgh: Churchill Livingstone, 1987: 131–47.

Hardisty RM Caen JP . Disorders of platelet function. In: Bloom AL Thomas DP eds. Haemostasis and thrombosis, 2nd edition. Edinburgh: Churchill Livingstone, 1987; 365–92.

De Groot PhG Sixma JJ . The role of von Willebrand factor in the vessel wall. Sem Thromb Haemost 1987; 13: 416–24.

Zwaginga JJ Ijsseldijk MJW de Groot PhG Vos J de Bos Kuil RLJ Sixma JJ . Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. Arterioscler Thromb 1991; 11: 733–44.

Stel HV Sakariassen KS de Groot PhG van Mourik JA Sixma JJ . The von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985; 65: 85–90.

Fressinaud E Baruch D Rothschild C Baumgartner HR Meyer D. Platelet von Willebrand factor: Evidence for its involvement in platelet adhesion to collagen. Blood 1987; 70: 1214–17.

Nieuwenhuis HK Sakariassen KS Houdijk WPM Nievelstein PFEM Sixma JJ . Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 1986; 68: 692–95.

Hindriks GA Sixma JJ de Groot PhG. Ascorbic acid increases the thrombogenicity of cellular matrices. Thromb Haemost 1991; 66: 505–509.

Hindriks G Ijsseldijk MJW Sonnenberg A Sixma JJ de Groot PhG. Platelet adhesion to laminin. Role of Ca²⁺ and Mg²⁺-ions, shear rate and platelet membrane glycoproteins. Blood 1992; 79: 928–35.

Agbanyo FR Sixma JJ de Groot PhG Languino LR Plow EF . Thrombospondin-platelet interactions: Role of divalent cations, wall shear rate and platelet membrane glycoproteins. J Clin Invest (in press).

Kieffer N Phillips DR . Platelet membrane glycoproteins: Functions in cellular interactions. Annu Rev Cell Biol 1990; 6: 329–57.

Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1–5.

Phillips DR Charo IF Scarborough RM . GPIIb-IIIa: The responsive integrin. Cell 1991; 65: 359–62.

Nurden AT . Platelet membrane glycoproteins and their clinical aspects. In: Verstraete M Vermylen J Lijnen R Arnout J eds. Thrombosis and haemostasis. Leuven: Leuven University Press, 1987: 93–125.

Modderman PW Admiraal LG Sonnenberg A von der Borne Aegkr . Glycoproteins V and Ib-IX form a nonvalent complex in the platelet membrane. J Biol Chem 1992; 267: 364–69.

Coller BS Peerschke EI Scudder LE Sullivan CA . Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99–110.

Sakariassen KS Bolhuis PA Sixma JJ . Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636–38.

Zucker MB Kim SJ McPherson J Grant RA . Binding of factor VIII to platelets in the presence of ristocetin. Br J Haematol 1977; 35: 535–49.

Read MS Sherma RW Brinkhous KM . Venom coagglutinin: An activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 1978; 75: 4514–18.

Kieffer N Phillips DR . Platelet membrane glycoproteins: Functions in cellular interaction. Annu Rev Cell Biol 1990; 6: 329–57.

Cruz MA Petersen E Turoi SM Handin RI . Functional analysis of a recombinant polypeptide which inhibits von Willebrand factor-binding to the platelet glycoprotein Ib-IX complex and to collagen. J Biol Chem 1992; 267: 1303–309.

Mohri H Fujimura Y Shima M Yoshioka A Houghten RA Ruggeri ZM Zimmerman TS . Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem 1988; 263: 17901–904.

Berliner S Niiya K Roberts JR Houghten RA Ruggeri ZM . Generation and characterization of peptide specific antibodies that inhibit von Willebrand factor binding to GPIIb-IIIa without interacting with other adhesive molecules. J Biol Chem 1988; 263: 7500–505.

Isenberg WM McEver RP Phillips DR Shuman MA Bainton DF . The platelet fibrinogen receptor. An immunogold-surface replica study of agonist induced ligand binding and receptor clustering. J Cell Biol 1987; 104: 1655–63.

Plow EF Pierschbacher MD Ruoslahti E Marguerie GA Ginsberg MH . The effect of Arg-Gly-Asp containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985; 82: 8057–61.

Savage B Ruggeri ZM . Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991; 266: 11227–33.

Weiss HJ Turitto VT Baumgartner HR . Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost 1991; 65: 202–205.

Pierschbacher MD Ruoshlati E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 1987; 262: 17294–98.

Smith JW Ruggeri ZM Kunicki TJ Cheresh DA . Interaction of integrin α_vβ₃ and glycoprotein IIb-IIIa with fibrinogen. J Biol Chem 1990; 264: 12267–71.

D'Souza SE Ginsberg MH Burke TA Lam SC-T Plow EF . Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 1988; 242: 91–93.

Cook JJ Trybulec M Lasz EC Kahn S Niewiarowski S. Binding of glycoprotein IIIa-derived peptide 217–231 to fibrinogen and von Willebrand factor and its inhibition by platelet glycoprotein. IIb/IIIa complex. Biochim Biophys Acta 1992; 1119: 312–21.

Kloczewiak M Timmons S Lukas TJ Hawiger J. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationships of peptides corresponding to the carboxy-terminal segment of the gamma-chain. Biochemistry 1984; 23: 1767–74.

Kloczewiak M Timmons S Bednarek A Sakon M Hawiger J. Platelet recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 1989; 28: 2915–19.

D'Souza SE Ginsberg MH Burke TA Plow EF . The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain in its a subunit. J Biol Chem 1990; 265: 3440–46.

D'Souza SE Ginsberg MH Matsueda GR Plow EF . A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 1991; 350: 66–68.

Taylor DB Gartner TK . A peptide corresponding to GPIIbα 300–312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin GPIIb/IIIa, inhibits the adhesion of platelets to at least four adhesive ligands. J Biol Chem 1992; 267: 11729–33.

Cardoy Y Houghten RA Hanson SR . RGDV peptide inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. J Clin Invest 1989; 84: 939–44.

Cisse-Thiam M Perreault P Chenu J Girma JP Meyer D Drouet L. Peptide 692–708 derived from the GPIb-binding domain of von Willebrand factor is a potent inhibitor of in vivo thrombosis in the guinea pig. Thromb Haemost 1991; 65: 1180 (abstract).

Nieuwenhuis HK Akkerman JWN Houdijk WPM Sixma JJ . Human blood platelets showing no response to collagen fail to express glycoprotein Ia. Nature 1985; 318: 470–72.

Santoro SA . Identification of a 160 000 dalton nplatelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46: 913–20.

Kunicki TJ Nugent DJ Staats SJ Orchekowski RP Wayner EA Carter WG . The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J Biol Chem 1988; 263: 4516–19.

Staatz W Rajpara SM Wayner EA Carter WG Santoro SA . The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg²⁺-dependent adhesion of platelets to collagen. J Cell Biol 1989; 108: 1917–24.

Tandon NN Lipsky RH Murgess WH Jamieson GA . Isolation and characterization of platelet glycoprotein IV (CD 36). J Biol Chem 1989; 264: 7570–75.

Moroi M Jung SM Okuma M Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack collagen induced aggregation and adhesion. J Clin Invest 1989; 84: 1440–45.

Deckmyn H van Houtte E Vermeylen J. Disturbed platelet aggregation to collagen associated with an antibody against an 85- to 90-kD platelet glycoprotein in a patient with prolonged bleeding time. Blood 1992; 79: 1466–71.

Piotrowicz RS Orchekowski RP Nugent DJ Yamada KY Kunicki TJ . Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J Cell Biol 1988; 106: 1359–64.

Sonnenberg A Modderman PW Hogenvorst F. Laminin receptor on platelets is the integrin VLA-6. Nature 1988; 360: 487–89.

Polanowska-Grabowska R Gear ARL . High-speed adhesion under conditions of rapid flow. Proc Natl Acad Sci USA 1992; 89: 5754–58.

Savage B Shattil SJ Ruggeri ZM . Modulation of platelet function through adhesion receptors. J Biol Chem 1992; 267; 11300–306.

Coller BS Scudder LE Beer J Gold HK Folts JD Cavagnaro J Jordan R Wagner C Iuliucci J Knight D Ghrayeb J Smith C Weisman H Berger H. Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agent. Ann N Y Acad Sci 1991; 614: 193–213.

De Groot PhG Sixma JJ . The role of von Willebrand factor in the vessel wall. Semin Thromb Haemost 1987; 13: 416–24.

De Groot PhG Reinders JH Sixma JJ . Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of these extracellular matrix towards platelets. J Cell Biol 1987; 104: 697–704.

Weiss HJ Turitto VT Baumgartner HR Nemerson Y Hoffmann T. Evidence for the presence of tissue factor activity on subendothelium. Blood 1989; 73: 968–75.

Zwaginga JJ Sixma JJ de Groot PhG. Activation of endothelial cells with various stimuli induces platelet thrombus formation on their matrix. Studies of a new ex vivo thrombosis model using low molecular weight heparin as anticoagulant. Arteriosclerosis 1990; 10: 49–61.

Weksler BB Ley CW Jaffe EA . Stimulation of endothelial prostacyclin production by thrombin, trypsin and the ionophore A23187. J Clin Invest 1978; 62: 923–30.

Weksler BB Jaffe EA . Prostacyclin and the endothelium. In: Gimbrone MA ed. Vascular endothelium in hemostasis and thrombosis. Edinburgh: Churchill Livingstone, 1986: 40–56.

Weiss HJ Turitto VT . Prostacyclin inhibits platelet adhesion and thrombus formation on subendothelium. Blood 1979; 53: 344–50.

Moncada S Palmer RMJ Higgs EA . Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–42.

Palmer RMJ Ferrige AG Moncada S. Nitric oxide accounts for the biological activity of endothelium derived relaxing factor. Nature 1987; 327: 524–26.

Palmer RMJ Ashton DS Moncada S. Vascular endothelial cells synthesize nitric oxide from 1-arginine. Nature 1988; 333: 664–66.

Ignarro LJ . Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein. Circ Res 1988; 65: 1–21.

Radomski MW Palmer RMJ Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148: 1482–89.

Radomsky MW Palmer RMJ Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639–46.

Martin W Villani GM Jothianandan D Furchott RF . Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708–16.

De Graaf JC Banga JD Moncada S Palmer RMJ de Groot PhG Sixma JJ . Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284–90.